Medicine and Dentistry
Pulmonary Hypertension
100%
Heart Failure with Preserved Ejection Fraction
77%
Persistent Truncus Arteriosus
61%
Heart Failure
59%
Hemodynamic
52%
Ejection Fraction
39%
Exercise
30%
Pulmonary Artery
25%
Disease
23%
Atrial Fibrillation
21%
Heart Right Ventricle Function
21%
Coarctation of the Aorta
19%
Echocardiography
18%
Bosentan
17%
Pulmonary Valve Replacement
17%
Tetralogy of Fallot
16%
Quality of Life
16%
Prevalence
15%
Apoplexy
15%
Patent Foramen Ovale
14%
Cardiac Magnetic Resonance Imaging
14%
Lung Artery Pressure
13%
Lung Vascular Resistance
13%
Heart Left Ventricle Enddiastolic Pressure
12%
Heart Left Ventricle Ejection Fraction
12%
Prosthesis
12%
Pulmonary Artery Occlusion Pressure
12%
Heart Disease
11%
Implantable Automatic Defibrillator
11%
Adipose Tissue
11%
Hypertension
11%
Sildenafil
11%
Heart Left Ventricle Filling Pressure
11%
Capillary
10%
Shunting
10%
Body Mass Index
10%
Deterioration
9%
Combination Therapy
9%
Anticoagulant Therapy
9%
Heart Output
9%
Randomized Controlled Trial
9%
Adult Congenital Heart Disease
9%
Exercise Test
8%
Heart Right Atrium Pressure
8%
Diagnosis
8%
Menstrual Cycle
8%
Systolic Blood Pressure
8%
Heart Ventricle Remodeling
8%
Cardiovascular System
8%
Systematic Review
7%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
88%
Congenital Heart Disease
47%
Heart Failure
37%
Bosentan
28%
Heart Failure with Preserved Ejection Fraction
22%
Prevalence
17%
Down Syndrome
13%
Disease
12%
Sildenafil
11%
Combination Therapy
10%
Deterioration
10%
Randomized Controlled Trial
9%
Cystatin C
7%
Placebo
6%
Symptom
6%
Brain Natriuretic Peptide
6%
Heart Ventricle Remodeling
5%
Filamin
5%
Biological Marker
5%
Maternal Hypertension
5%
Eisenmenger Complex
5%
Peripheral Vasodilating Agent
5%
Survival Rate
5%
Pyroglutamic Acid
5%
Fibrosis
5%
Lung Embolism
5%
Ventricular Noncompaction
5%
Iron Deficiency
5%
Congestive Heart Failure
5%
Heart Left Ventricle Failure
5%
Malignant Neoplasm
5%
Polycyclic Aromatic Hydrocarbon
5%
Keyphrases
Congenital Heart Disease
17%
Exercise Capacity
14%
Heart Failure with Preserved Ejection Fraction (HFpEF)
14%
Adult Patients
12%
Pulmonary Hypertension
11%
Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
11%
Down Syndrome
11%
Bosentan
11%
Pulmonary Arterial Hypertension
11%
Right Ventricular Function
11%
Fontan Circulation
11%
Interatrial Shunt
10%
Heart Failure Patients
10%
Quality of Life
9%
Pulmonary Capillary Wedge Pressure
9%
Patients with Heart Failure
8%
Cardiovascular Mortality
7%
Shunt
7%
Adult Congenital Heart Disease
7%
Preserved Ejection Fraction
7%
Heart Failure Events
7%
Hazard Ratio
6%
Cardiopulmonary Exercise Testing
6%
Exercise Efficiency
6%
Pulmonary Vascular Response
6%
Renal Function
6%
Heart Failure
6%
Clinical Outcomes
6%
Atrial Fibrillation
6%
Truncal Valve Regurgitation
5%
Double Outlet Right Ventricle
5%
Menstrual Cycle
5%
Beneficial Effects
5%
Chronic Pulmonary Embolism
5%
Refractory Hypertension
5%
Cyanotic Congenital Heart Disease
5%
Pulmonary Valve Replacement
5%
Survival Rate
5%
Pulmonary Vasodilators
5%
Dilution Curve
5%
Cardiac Shunt
5%
Edwards Sapien Valve
5%
TBX4
5%
Small Patella Syndrome
5%
Valve Implantation
5%
Netherlands
5%
Meta-analysis
5%
Grown-up Congenital Heart Disease
5%
20-year Follow-up
5%
Cardiac Structure
5%
